Lipella Pharma (LIPO): Rentabilitas operasi

LIPO (Lipella Pharma) - tandha merek perusahaan

The historical operating margin on the GURU.Markets chart for Lipella Pharmaceuticals (LIPO) demonstrates volatility, with the indicator standing at 0.00. This price action reflects the implementation of liposomal drug delivery, the scaling of urogenital inflammation therapy, and the development of the LP-10 drug for bladder cancer. These factors determine the current business efficiency within the specialty pharmaceuticals segment.

lipella.com (LIPO): Rentabilitas operasi saka 28.04.2023 nganti 19.07.2025

lipella.com - rincian analitis lan metrik utama (LIPO)

- rega saham lan konsensus proyeksi valuasi:
Ringkesan analitik perusahaan:Lipella, LIPO
Produk merek Lipella Pharmaceuticals

Operating margin measures cost management efficiency by determining the share of profit from core operations before interest and taxes relative to total revenue. By analyzing the operating profit margin before interest and taxes, an investor assesses the ability of Lipella Pharmaceuticals (LIPO) to monetize therapeutic agents for tissue regeneration and withstand costs when scaling the supply of drugs to clinics.

Analisis pesaing Lipella Pharmaceuticals

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Rentabilitas operasi ANI Pharmaceuticals Inc|MNKD: Tingkat bathi operasi|Margin dodolan operasi AMPH (Amphastar)|PCRX - Rentabilitas dodolan operasi|Margin operasi SPRY (ars-pharma.com)|Tingkat bathi operasi TBPH|Aquestive Therapeutics, Inc. - Margin operasi|scpharmaceuticals.com - Rasio bathi operasi|Tectonic (TECX) - Rentabilitas operasi|Margin dodolan operasi Tonix Pharmaceuticals Inc.|Rentabilitas operasi sxtchina.com|Margin dodolan operasi Eupraxia Pharmaceuticals (EPRX)|Margin operasi BHST|EXOZ - Rentabilitas dodolan operasi|Oramed - Margin dodolan operasi|Entera Bio Ltd. (ENTX) - Rentabilitas dodolan operasi|HYFT - Rentabilitas operasi|ABVC: Rentabilitas operasi|CPIX: Margin operasi|Quantum BioPharma Ltd. - Tingkat bathi operasi|FGEN (FibroGen Corp) - Margin operasi|Telomir Pharma (TELO) - Rentabilitas kegiatan operasi|Rentabilitas operasi Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Tingkat bathi operasi|Rentabilitas operasi Rallybio Corporation RLYB|LEXX: Rentabilitas dodolan miturut bathi operasi|PULM - Rentabilitas operasi|Tingkat bathi operasi PTHL (Pheton Holdings)|Aptorum (APM) - Rentabilitas operasi|LYRA (Lyra Therapeutics) - Rentabilitas operasi|Rentabilitas operasi Impact BioMedical Inc|TNF Pharmaceuticals - Margin bathi operasi|Margin operasi YCBD|Margin operasi PainReform Ltd. (PRFX)|Rentabilitas operasi Altamira Therapeutics Ltd CYTO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.